REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.